
Number of publications published per year by Khalili, Mandana. (Source : PubMed)

Distribution of publications types for Khalili, Mandana. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

A glimpse of future hepatitis C virus treatment paradigms.
Hepatology
2010;51;2
Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methylphenyl) (tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests.
Arzneimittelforschung
2010;60;1
Offspring sex ratio at birth in mountain climbers.
J Epidemiol Community Health
2009;63;7
Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory.
Lancet
2009;373;9668
Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl) (cyclohexyl)] 4-piperidinol and 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4-piperidinol as two new phencyclidine derivatives.
Arzneimittelforschung
2009;59;4
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
Liver Transpl.
2008;14;10

Imaging of gastrointestinal tract infection.
Semin Roentgenol
2007;42;2
Expression of p21WAF in salivary gland mucoepidermoid carcinoma and its relation to histologic grade.
Int. J. Surg. Pathol.
2007;15;1


Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
Clin Transplant
2006;20;1




Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial.
Dig. Dis. Sci.
2005;50;6
[ See timeline ] [ See all publications ]
means that Khalili, Mandana has 12 papers cited a least 12 times - methodology
University of California, San Francisco, California, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.